Monthly Archive: February 2024

Yesterday the Daily Mail published an article based on my new book, Dispatches From the Land of Alzheimer’s. I think the Daily Mail editors did a really good job of organizing excerpts from the book...

On January 31, Biogen put out a press release indicating that it “plans to reprioritize its resources in Alzheimer’s disease” by halting development and marketing of the anti-amyloid monoclonal antibody aducanumab (Aduhelm). Patients currently...